Innovative Product TheraB Medical's flagship product, SnugLit, offers a unique, portable, and wearable phototherapy solution that supports maternal bonding and breastfeeding during jaundice treatment. This innovation presents a compelling opportunity to expand into neonatal care markets seeking holistic and patient-centered solutions.

Growing Market Presence With plans to commercialize SnugLit in both the US and India, TheraB Medical is targeting two large and diverse healthcare markets. This opens avenues for partnerships with hospitals, pediatric clinics, and maternal care providers keen on adopting advanced neonatal treatment technologies.

Leadership Expansion The recent appointment of a new CEO, Chris Mathia, indicates strategic growth and leadership strengthening. This positions the company well to pursue new sales channels and enterprise collaborations in the pediatric and neonatal device sectors.

Targeted Clinical Development With dedicated clinical development leadership and collaborative input from nurses and mothers, TheraB Medical demonstrates a customer-centric approach, fostering trust and acceptance for its innovative solutions—an advantage in gaining market traction.

Funding and Revenue Potential Operating within the $1M to $10M revenue range and attracting interest from investors, TheraB Medical presents opportunities for strategic alliances, distribution partnerships, and joint ventures that accelerate growth and sales expansion in neonatal healthcare.